samedan logo
 
 
 
spacer
home > ebr > spring 2003 > where to biomanufacture? one state's efforts to answer the question
PUBLICATIONS
European Biopharmaceutical Review

Where to Biomanufacture? One State's Efforts to Answer the Question

Where will your company manufacture its next biopharmaceutical product for the North American market? This is a question that looms large for the biotechnology and pharmaceutical industries because an estimated 1,000 large-molecule drugs are moving through clinical trials and toward the marketplace worldwide, threatening to overwhelm current biomanufacturing capacity. Experts in the industry widely agree there is, and will be for the immediate future, an acute global shortage of capacity to produce these products.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Barry D Teater, Director of Corporate Communications at the North Carolina Biotechnology Center

Barry D Teater is in his 17th year with the North Carolina Biotechnology Center, the world's first government-based initiative in biotechnology economic development. He is responsible for the Center's websites, publications, media relations, visitor briefings, trade show exhibits, advertising and related activities.

He holds Bachelor's and Master's degrees in Journalism from Eastern Kentucky University and the University of North Carolina at Chapel Hill, respectively.
 

spacer
Barry D Teater
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Turkish Cargo maintains its steady growth.

According to the data obtained by WACD, the international air cargo information provider, in May; Turkish Cargo, the global air cargo brand providing service to 124 countries around the world, increased its tonnage rate by 7.1 percent, and grew substantially across the industry which shrank by 5.1 percent in the global air cargo market.
More info >>

White Papers

Tightening Your Supply Chain Against Counterfeits

World Courier

As today’s global pharmaceutical supply chain grows increasingly longer and more complex, each link provides added opportunity for counterfeiters. While pending regulatory changes promise to tighten the supply chain with respect to production and distribution entities and new packaging technologies will make the identification of counterfeit products easier, the logistics of global distribution remains a weak link. How can the pharmaceutical shipper ensure the security of the supply chain over thousands of miles and extended periods of time when the product is no longer in his possession?
More info >>

 
Industry Events

12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology

8-11 February 2021, Vienna, Austria

In continuation of the very successful scientific meetings in Budapest, Paris, Berlin, Florence, Geneva, Barcelona, Malta, Istanbul, Lisbon, Glasgow and Granada, the 12th PBP World will be held in Vienna from 8-11 Feb 2021. This every two year held conference has gained an ever increasing impact among the pharmaceutical scientists: With up to 1000 submitted abstracts and about 1300 participants it has become a well-established major meeting, attracting scientists from all over the world.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement